Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept + MTX Early Response in RA
NCT00767325Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2008
- Primary completion
- Oct 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 8
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Dec 2008; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00767325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767325.